tiprankstipranks
Advertisement
Advertisement
Neurotech taps $3.15m R&D tax loan to fund Phase III ASD trials
PremiumCompany AnnouncementsNeurotech taps $3.15m R&D tax loan to fund Phase III ASD trials
30d ago
Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy
Premium
Company Announcements
Neurotech Secures FDA IND Clearance for NTI164, Bolstering Global ASD Strategy
1M ago
Neurotech International Issues 19.5 Million New Unlisted Options
Premium
Company Announcements
Neurotech International Issues 19.5 Million New Unlisted Options
1M ago
Maybank Securities Exits Substantial Holder Position in Neurotech International
PremiumCompany AnnouncementsMaybank Securities Exits Substantial Holder Position in Neurotech International
4M ago
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
Premium
Company Announcements
Neurotech Showcases Paediatric Neurology Drug NTI164 at Hong Kong Investment Summit
4M ago
Neurotech Director Mark Davies Increases Indirect Shareholding
Premium
Company Announcements
Neurotech Director Mark Davies Increases Indirect Shareholding
5M ago
Neurotech Investors Back Capital Raisings and Director Participation at General Meeting
PremiumCompany AnnouncementsNeurotech Investors Back Capital Raisings and Director Participation at General Meeting
5M ago
Neurotech Narrows Half-Year Loss as Revenue Doubles
Premium
Company Announcements
Neurotech Narrows Half-Year Loss as Revenue Doubles
6M ago
Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
Premium
Company Announcements
Neurotech’s NTI164 Shows Strong Long-Term Safety in Key Toxicology Study
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100